跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,635 条关于
“MEK inhibitor”
全部
25,635
临床试验
14,723
药物
4,623
机构
73
资讯
6,216
9个月前
Pasithea Therapeutics Secures $60 Million Funding to Advance MEK Inhibitor for Neurofibromatosis Treatment
去年
Pasithea's PAS-004 Outperforms FDA-Approved MEK Inhibitor in Preclinical IBD Study
去年
FDA Approves SpringWorks' Gomekli (Mirdametinib) for Neurofibromatosis Type 1
去年
Pasithea Therapeutics Raises $6.3 Million to Advance MEK Inhibitor for Neurofibromatosis Type 1
5个月前
ASCO Expands TAPUR Study with First Antibody-Drug Conjugate and BRAF/MEK Inhibitor Combination
去年
Phase 3 Trial Shows Promise for Adjuvant BRAF/MEK Inhibitor Combination in High-Risk Melanoma
去年
European Commission Approves First MEK Inhibitor for NF1-Associated Plexiform Neurofibromas in Adults and Children
9个月前
Pasithea Therapeutics Receives $1 Million ALS Association Grant to Advance PAS-004 MEK Inhibitor in Phase 1 ALS Trial
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
2个月前
Biomarker-Guided Drug Combinations May Overcome Treatment Resistance in Advanced Melanoma
第 1 页,共 622 页
上一页
下一页